Correlation Between Enanta Pharmaceuticals and Artelo Biosciences
Can any of the company-specific risk be diversified away by investing in both Enanta Pharmaceuticals and Artelo Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enanta Pharmaceuticals and Artelo Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enanta Pharmaceuticals and Artelo Biosciences, you can compare the effects of market volatilities on Enanta Pharmaceuticals and Artelo Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enanta Pharmaceuticals with a short position of Artelo Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enanta Pharmaceuticals and Artelo Biosciences.
Diversification Opportunities for Enanta Pharmaceuticals and Artelo Biosciences
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Enanta and Artelo is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Enanta Pharmaceuticals and Artelo Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artelo Biosciences and Enanta Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enanta Pharmaceuticals are associated (or correlated) with Artelo Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artelo Biosciences has no effect on the direction of Enanta Pharmaceuticals i.e., Enanta Pharmaceuticals and Artelo Biosciences go up and down completely randomly.
Pair Corralation between Enanta Pharmaceuticals and Artelo Biosciences
Given the investment horizon of 90 days Enanta Pharmaceuticals is expected to generate 1.38 times more return on investment than Artelo Biosciences. However, Enanta Pharmaceuticals is 1.38 times more volatile than Artelo Biosciences. It trades about 0.02 of its potential returns per unit of risk. Artelo Biosciences is currently generating about -0.03 per unit of risk. If you would invest 585.00 in Enanta Pharmaceuticals on December 28, 2024 and sell it today you would lose (14.00) from holding Enanta Pharmaceuticals or give up 2.39% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Enanta Pharmaceuticals vs. Artelo Biosciences
Performance |
Timeline |
Enanta Pharmaceuticals |
Artelo Biosciences |
Enanta Pharmaceuticals and Artelo Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Enanta Pharmaceuticals and Artelo Biosciences
The main advantage of trading using opposite Enanta Pharmaceuticals and Artelo Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enanta Pharmaceuticals position performs unexpectedly, Artelo Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artelo Biosciences will offset losses from the drop in Artelo Biosciences' long position.Enanta Pharmaceuticals vs. Monte Rosa Therapeutics | Enanta Pharmaceuticals vs. Design Therapeutics | Enanta Pharmaceuticals vs. Werewolf Therapeutics | Enanta Pharmaceuticals vs. Ikena Oncology |
Artelo Biosciences vs. Curis Inc | Artelo Biosciences vs. Salarius Pharmaceuticals | Artelo Biosciences vs. Akeso, Inc | Artelo Biosciences vs. Basilea Pharmaceutica AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Commodity Directory Find actively traded commodities issued by global exchanges |